International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism

被引：0
作者：
Mei Tian
Chuantao Zuo
A. Cahid Civelek
Ignasi Carrio
Yasuyoshi Watanabe
Keon Wook Kang
Koji Murakami
John O. Prior
Yan Zhong
Xiaofeng Dou
Congcong Yu
Chentao Jin
Rui Zhou
Fengtao Liu
Xinyi Li
Jiaying Lu
Hong Zhang
Jian Wang
机构：
[1] Fudan University,Department of Nuclear Medicine and PET Center, Huashan Hospital
[2] The Second Affiliated Hospital of Zhejiang University School of Medicine,Department of Nuclear Medicine and PET Center
[3] Fudan University,Human Phenome Institute
[4] Fudan University,National Center for Neurological Disorders & National Clinical Research Center for Aging and Medicine, Huashan Hospital
[5] Johns Hopkins Medicine,Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging
[6] Autonomous University of Barcelona,Research Institute and Department of Nuclear Medicine, Hospital Sant Pau
[7] RIKEN Center for Biosystems Dynamics Research,Laboratory for Pathophysiological and Health Science
[8] Seoul National University College of Medicine,Department of Nuclear Medicine
[9] Juntendo University Hospital,Department of Radiology
[10] Lausanne University Hospital,Department of Nuclear Medicine and Molecular Imaging
[11] Fudan University,Department of Neurology, Huashan Hospital
[12] Key Laboratory of Medical Molecular Imaging of Zhejiang Province,Key Laboratory for Biomedical Engineering of Ministry of Education
[13] The College of Biomedical Engineering and Instrument Science of Zhejiang University,undefined
[14] Zhejiang University,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2024年 / 51卷
关键词：
Dopamine; Positron emission tomography (PET); Brain imaging; Parkinsonism; Expert consensus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：434 / 442
页数：8
相关论文
共 150 条
  • [1] Oravivattanakul S(2016)Dopamine transporter (DaT) Scan utilization in a movement disorder center Mov Disord Clin Pract 3 31-35
  • [2] Benchaya L(2018)Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Lancet Neurol. 17 939-953
  • [3] Wu G(2020)PET and SPECT imaging of the brain: history, technical considerations, applications, and radiotracers Semin Ultrasound CT MR 41 521-529
  • [4] Davis KM(2021)Transpathology: molecular imaging-based pathology Eur J Nucl Med Mol Imaging 48 2338-2350
  • [5] Ryan JL(2020)EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in parkinsonian syndromes 1.0 Eur J Nucl Med Mol Imaging. 47 1885-1912
  • [6] Aaron VD(2015)MDS clinical diagnostic criteria for Parkinson’s disease Mov Disord 30 1591-1601
  • [7] Sims JB(2020)Research criteria for the diagnosis of prodromal dementia with Lewy bodies Neurology 94 743-755
  • [8] Tian M(2018)Clinical, dopaminergic, and metabolic correlations in Parkinson disease: a dual-tracer PET study Clin Nucl Med 43 562-571
  • [9] He X(2021)Dopaminergic and metabolic correlations with cognitive domains in non-demented Parkinson’s disease Front Aging Neurosci 13 585-591
  • [10] Jin C(1996)An [18F]dopa-PET and clinical study of the rate of progression in Parkinson’s disease Brain 119 758-766
12345678910